Novartis has selected Qualcomm Life as a global digital health collaborator for its Trials of The Future program. Qualcomm’s 2net Platform will serve as a global connectivity platform for collecting and aggregating medical device data during clinical trials, aimed at improving the convenience and speed of capturing study participant data and test results.   The Trials of The Future program is designed to leverage health care technology to improve the experience of clinical trial participan...